In focus · trending topic

World Muscle Society

1 stories · following the connections

aTyr Pharma to Present Final Data for Resolaris Phase 1b/2 Trial in Patients with Early-Onset Facioscapulohumeral Muscular Dystrophy at the 22nd International Annual Congress of the World Muscle Society

By Nasdaq OMXSep 27, 2017, 12:01 PM UTC